2.26
price up icon5.61%   0.12
pre-market  시장 영업 전:  2.26  
loading

Aptevo Therapeutics Inc (APVO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Research and Development
4.48%
3.752
3.591 3.887 5.462 4.168
Operating Income/Loss
9.38%
-6.983
-6.384 -6.561 -8.178 -7.756
Income/Loss From Continuing Operations Before Tax
10.30%
-6.834
-6.196 -6.334 -7.948 2.773
Income/Loss From Continuing Operations After Tax
10.30%
-6.834
-6.196 -6.334 -7.948 1.827
Income/Loss From Discontinued Operations, Net Of Tax
100.00%
-
0.293 - - 0.946
Net Income/Loss
15.77%
-6.834
-5.903 -6.334 -7.948 2.773
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
78.73%
0.6867
3.2281 12.58 6.4822 7.0223
Diluted Average Shares
78.73%
0.6867
3.2281 12.58 6.4822 7.0223
Basic Earnings Per Share
7,007%
-9.95
-0.14 -0.50 -1.23 0.39
Diluted Earnings Per Share
7,007%
-9.95
-0.14 -0.50 -1.23 0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
자본화:     |  볼륨(24시간):